06990.HK
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
HKSE · Healthcare · Biotechnology · CN
HKD 489.40
−1.49%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +51.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +36.8%
- EBITDA
- —
- EBIT
- —
- Net income
- -43.2%
- EPS
- -38.3%
- Free cash flow
- +40.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025